Evidence map›Paper›PMID 42001046›Full record

ArticleBMC urology2026

Efficacy and safety of mirabegron versus solifenacin in the treatment of overactive bladder in children: a systematic review and meta-analysis.

Mostafa Shaheen, Omar Mohamed Ali, Abdullah A Draz, Amro K Barakat, Ahmed Elghattas, Toqa Elbaz, Iyad Walid, Tasnim Tarboush, Asmaa Elsayed, Tasneem Mahmoud and 3 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Mostafa ShaheenFaculty of Medicine, Mansoura University, Mansoura, 35516, Egypt. mostafashaheen@std.mans.edu.eg.ORCID http://orcid.org/0009-0000-8966-3908
Omar Mohamed AliFaculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Abdullah A DrazFaculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Amro K BarakatFaculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Ahmed ElghattasFaculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Toqa ElbazFaculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Iyad WalidFaculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Tasnim TarboushFaculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Asmaa ElsayedFaculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Tasneem MahmoudFaculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Esraa Mohamed ElkhateebFaculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Abdallah Adel NofalFaculty of Medicine, Mansoura University, Mansoura, 35516, Egypt.
Emad SamaanDepartment of Internal Medicine - Nephrology Unit, Mansoura University Hospitals, Mansoura, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ChildrenMirabegronOveractive BladderSolifenacin

Identifiers

PMID42001046
PMCPMC13101355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.